Exclusion Criteria:~* Significant risk of suicidal or violent behavior in the judgment of the investigator~*
Adverse events from the previous study (EVP-6124-024 or EVP-6124-025) that have not resolved, are moderate or
severe, judged to be possibly related or related to study drug, and considered by the investigator to be a
contraindication to extension study participation~* Any condition that would make the subject in the judgment
of the investigator unsuitable for the study~* Female subjects who are pregnant, nursing, or planning to become
pregnant during the extension study
